Skip Nav Destination
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
PERSPECTIVES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
Clinical Trials & Observations
Barbara A. Konkle,Oleksandra Stasyshyn,Pratima Chowdary,David H. Bevan,Tim Mant,Midori Shima,Werner Engl,Jacqueline Dyck-Jones,Monika Fuerlinger,Lisa Patrone,Bruce Ewenstein,Brigitt Abbuehl
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
TRANSPLANTATION
BLOOD WORK
-
Cover Image
Cover Image
A multinucleated megakaryocyte, a sign of myelodysplasia in mouse bone marrow. See the article by Zhou et al on page 1057.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals